Right on the heels of our press release announcing a deal with Novo Nordisk, we're thrilled to see this NY Times coverage of the partnership and Variant Bio's ethics-first approach to drug discovery: nytimes.com/2025/01/07/healt…
Variant Bio retweeted
Awesome story. Awesome team at Variant Bio.
One of the great joys of starting this company has been getting to work with @bborrell more. He's one of the finest science writers around, and it's such an honor to publish him.
(Best of all, we grew up together and were the writer dorks at school. How funny to end up here together all these years later.)
You will not read a better story this week. corememory.com/p/variant-bio…
Variant Bio retweeted
She's not wrong
best story ever just dropped!!!!! i love getting asked to read a piece before publishing and witnessing a banger be born corememory.com/p/variant-bio…
Variant Bio retweeted
An incredible story by @bborrell and work from @VariantBio.
It’s a reminder that science is a long game—and that technology companies can be both world-changing and community-focused.
Also, great science journalism is a public good worth supporting. Props to @ashleevance and team.
best story ever just dropped!!!!! i love getting asked to read a piece before publishing and witnessing a banger be born corememory.com/p/variant-bio…
New coverage in @corememory tells the origins of @VariantBio’s first drug candidate, and the power of human genetics to discover new medicines: medium.com/variantbio/from-t…
Variant Bio retweeted
A researcher studying flatworms for decades may have discovered some gene variants key to the next blockbuster drug.
This is our story by @bborrell on how @VariantBio is finding new therapies in places everyone else has ignored. corememory.com/p/variant-bio…
New piece out about @VariantBio's lead drug program in pulmonary fibrosis and Dr. Alain Dessein, our inspiring research collaborator in Uganda:
A researcher studying flatworms for decades may have discovered some gene variants key to the next blockbuster drug.
This is our story by @bborrell on how @VariantBio is finding new therapies in places everyone else has ignored. corememory.com/p/variant-bio…
Announcing our newest paper on the genetics of kidney disease co-authored with research partners from South Africa and Uganda: medium.com/variantbio/new-pu…
Thanks to Dr. @hibababiker2 for representing @VariantBio and sharing our approach to benefit sharing at #ASHG26 in Montreal last week!
3
196
Findings from our recent papers in @ScienceMagazine and @NatureComms include health risks and drug-target leads the largest databases miss: medium.com/variantbio/two-pa…
Variant Bio retweeted
With co-author @stephanecastel of @VariantBio in front of our cover of @ScienceMagazine at ASHG @GeneticsSociety in Montreal. Come to their booth and get a free copy! Missing my co-senior author @KeoluFox.
Variant Bio retweeted
Lux family co @VariantBio
we created + funded this company to find outlier people in outlier parts of the world with outlier traits...
to develop new drugs for all of the rest of us.
Out today on the cover of @ScienceMagazine: work led by @KeoluFox (UCSD) and Alexander Ioannidis (Stanford) with @VariantBio. Polynesians experienced founder effects 10x stronger than Finland’s, with big implications for drug discovery and clinical care: science.org/doi/10.1126/scie…
Out today on the cover of @ScienceMagazine: work led by @KeoluFox (UCSD) and Alexander Ioannidis (Stanford) with @VariantBio. Polynesians experienced founder effects 10x stronger than Finland’s, with big implications for drug discovery and clinical care: science.org/doi/10.1126/scie…
Dr. Sarah LeBaron von Baeyer from Variant Bio presenting with our brilliant partner Dr. June Fabian from the University of the Witwatersrand on how we have together implemented the community-driven distribution of financial benefits for genomics research projects in South Africa.
2
155
Variant Bio leverages AI-powered Inference platform in an expanded collaboration with @Boehringer: medium.com/variantbio/expand…
Thrilled to announce our latest drug development collaboration! We are now expanding our existing partnership with @Boehringer into cardiovascular disease for a total potential deal value exceeding $250 mm: prnewswire.com/news-releases…
Check out this upcoming webinar by our very own @OliviaG_PhD! Register here 👉 zoom.us/webinar/register/WN_…
2
178
Variant Bio’s Senior Director of Ethics & Engagement discusses lessons learned from educational and health initiatives in Rwanda: medium.com/variantbio/taking…
1
685
We recently wrapped up recruitment for a genomic research study in Tahiti in partnership with Novo Nordisk and GHICL: medium.com/variantbio/conclu…
1
421
We are thrilled to announce our latest paper published with the Faroe Genome (FarGen) project and the University of Copenhagen: medium.com/variantbio/paper-…
2
230
Variant Bio retweeted
Join our webinar with Dr. Olivia Gray (@VariantBio) tomorrow!
Learn how multiomics revealed mechanisms affecting creatinine-based eGFR estimates in African ancestry populations.
📅 27 May
🕒 11 am EDT | 5 pm CEST
🔗bit.ly/4nIaF1Q
Can genetics bias kidney disease biomarkers?
In our next webinar, Dr. Olivia Gray (@VariantBio) will show how multiomics revealed mechanisms affecting creatinine-based eGFR estimates in African ancestry populations.
📅 27 May
🕑 11 am EDT | 5 pm CEST
🔗 bit.ly/4nIaF1Q
















